Pfizer and BioNTech announced that they are beginning clinical trials of their omicron-specific covid-19 vaccine.
The trial will enroll up to 1,420 healthy adults between the ages of 18 and 55.
Learn more details in the video.
Now you can see non-English news...
2022-01-25T15:51:17.869Z
Pfizer and BioNTech announced that they are beginning clinical trials of their omicron-specific covid-19 vaccine. The trial will cover up to 1,420 | Health | CNN
Pfizer and BioNTech announced that they are beginning clinical trials of their omicron-specific covid-19 vaccine.
The trial will enroll up to 1,420 healthy adults between the ages of 18 and 55.
Learn more details in the video.
© Communities 2019 - Privacy
The information on this site is from external sources that are not under our control.